Oslo University Hospital secures €4.9 million EU grant for older cancer patient care
Horizon Europe has granted €4.9m to Oslo University Hospital (OUS) Radiumhospitalet to lead an international research project aimed at improving…
Author: Team Health Accessible
PhotoMel investigates factors increasing melanoma risk in young adults
A major European research project led by the Medical University of Vienna will investigate how environmental factors may increase melanoma…
AI joins the quest to find new treatments for rare neuromuscular diseases
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach…
Justicia carnea extract alleviates oxidative stress in pancreatitis
Background and objectives Chronic pancreatitis is an inflammatory disease and is difficult to manage despite advancements in medical science. This…
Hypoxia-gated AAV enables targeted treatment for advanced NSCLC
Adeno‑associated virus (AAV) vectors offer safety and durable expression but lack tumor specificity. This hypothesis proposes an NSCLC‑directed, hypoxia‑responsive AAV…
Mesenchymal drift may explain how aging cells lose their identity
A new review argues that aging may not be just a collection of molecular defects, but a progressive drift in…
New T-cell engager therapy shows effectiveness in advanced solid tumors
A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University…
The right seafood choices can help diets meet health and climate goals
A new review shows fish can help bridge nutrition and sustainability goals, but only when consumers choose lower-impact species and…
Higher-dose ocrelizumab depletes more B cells but does not slow MS progression
A major analysis shows that more drug exposure does not always mean better disease control, as high-dose ocrelizumab cleared more…
Novel PRRT approach shows promise in advanced neuroendocrine tumors
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have…